Indivior to pay $385m to settle Suboxone monopoly case
Addiction treatment drug maker Indivior said it had agreed to pay $385m to resolve the final lawsuit claims against it in the long-running Suboxone anti-trust case.
Stay updated with breaking news from Mark Crossley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Addiction treatment drug maker Indivior said it had agreed to pay $385m to resolve the final lawsuit claims against it in the long-running Suboxone anti-trust case.
Indivior Reaches Agreement with Direct Purchasers to Resolve Antitrust Multi-District Litigation; Provides Preliminary Q3 and YTD 2023 Results October 23 2023 THIS...
Indivior PLC (NASDAQ: INDV) shares are trading higher by around 6% after the company inked a deal to
Drugmaker Indivior has agreed to pay $385million (£316million) to settle lawsuits brought by drug wholesalers in the US.
Stock prices in London opened lower on Monday, while oil and gold prices fell, as tensions in the Middle East continue to shake markets. The FTSE 100 index opened down 24.47 points, 0.3%, at...